125 related articles for article (PubMed ID: 33153388)
1. Impact of Pharmacist-Led Patient Education in an Ambulatory Cancer Center: A Pilot Quality Improvement Project.
Park D; Patel S; Yum K; Smith CB; Tsao CK; Kim S
J Pharm Pract; 2022 Apr; 35(2):268-273. PubMed ID: 33153388
[TBL] [Abstract][Full Text] [Related]
2. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
[TBL] [Abstract][Full Text] [Related]
3. Impact of pharmacist interventions on cost avoidance in an ambulatory cancer center.
Randolph LA; Walker CK; Nguyen AT; Zachariah SR
J Oncol Pharm Pract; 2018 Jan; 24(1):3-8. PubMed ID: 27682600
[TBL] [Abstract][Full Text] [Related]
4. Impact of pharmacist involvement in the transitional care of high-risk patients through medication reconciliation, medication education, and postdischarge call-backs (IPITCH Study).
Phatak A; Prusi R; Ward B; Hansen LO; Williams MV; Vetter E; Chapman N; Postelnick M
J Hosp Med; 2016 Jan; 11(1):39-44. PubMed ID: 26434752
[TBL] [Abstract][Full Text] [Related]
5. Incorporating a clinical oncology pharmacist into an ambulatory care pharmacy in pediatric hematology-oncology and transplant clinic: Assessment and significance.
Ali K; Al-Quteimat O; Naseem R; Malhi SM; Wajdi M; Jahan N; Ansari SH; Shamsi TS
J Oncol Pharm Pract; 2021 Jun; 27(4):815-820. PubMed ID: 32633660
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a Pharmacist Led Oral Chemotherapy Clinic: A Pilot Program in the Gastrointestinal Oncology Clinic at an Academic Medical Center.
Darling JO; Raheem F; Carter KC; Ledbetter E; Lowe JF; Lowe C
Pharmacy (Basel); 2020 Mar; 8(1):. PubMed ID: 32244894
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the patient-perceived impact of clinical pharmacy services and proactive follow-up care in an ambulatory chemotherapy unit.
Crespo A; Tyszka M
J Oncol Pharm Pract; 2017 Jun; 23(4):243-248. PubMed ID: 26911478
[TBL] [Abstract][Full Text] [Related]
8. A pilot study to assess the pharmacy impact of implementing a chemotherapy-induced nausea or vomiting collaborative disease therapy management in the outpatient oncology clinics.
Jackson K; Letton C; Maldonado A; Bodiford A; Sion A; Hartwell R; Graham A; Bondarenka C; Uber L
J Oncol Pharm Pract; 2019 Jun; 25(4):847-854. PubMed ID: 29587608
[TBL] [Abstract][Full Text] [Related]
9. Physician-pharmacist collaboration for oral chemotherapy monitoring: Insights from an academic genitourinary oncology practice.
Holle LM; Puri S; Clement JM
J Oncol Pharm Pract; 2016 Jun; 22(3):511-6. PubMed ID: 25900102
[TBL] [Abstract][Full Text] [Related]
10. Optimizing patient education of oncology medications: A descriptive survey of pharmacist-provided patient education in Canada.
Donald G; Scott S; Broadfield L; Harding C; Meade A
J Oncol Pharm Pract; 2019 Mar; 25(2):295-302. PubMed ID: 29020857
[TBL] [Abstract][Full Text] [Related]
11. Impact of a transition-of-care pharmacist during hospital discharge.
Balling L; Erstad BL; Weibel K
J Am Pharm Assoc (2003); 2015; 55(4):443-8. PubMed ID: 26161488
[TBL] [Abstract][Full Text] [Related]
12. A retrospective study comparing interventions by oncology and non-oncology pharmacists in outpatient chemotherapy.
Kaya M; Nakamura K; Nagamine M; Suyama Y; Nakajo M; Uchida R; Hagikura K; Kanda A; Sugiyama K; Sugiyama R; Nakagaki S; Kimura M
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1371. PubMed ID: 33739629
[TBL] [Abstract][Full Text] [Related]
13. Pharmacist-Led Discharge Medication Counseling and its Corresponding Impact on Medication Adherence and Hospital Readmission Rates.
Cunningham S; Kinsey JD
Innov Pharm; 2020; 11(3):. PubMed ID: 34007627
[No Abstract] [Full Text] [Related]
14. Impact of pharmacist discharge medication therapy counseling and disease state education: Pharmacist Assisting at Routine Medical Discharge (project PhARMD).
Sarangarm P; London MS; Snowden SS; Dilworth TJ; Koselke LR; Sanchez CO; D'Angio R; Ray G
Am J Med Qual; 2013; 28(4):292-300. PubMed ID: 23033542
[TBL] [Abstract][Full Text] [Related]
15. Impact of Adherence Education and Monitoring on Community Pharmacy Performance Scores and Patient Satisfaction.
Sprouse C; Grant M; Remines J; Nadpara P; Goode JV
Innov Pharm; 2020; 11(3):. PubMed ID: 34007625
[TBL] [Abstract][Full Text] [Related]
16. Improving direct pharmacist counseling rates for oral oncolytic medications at an outpatient oncology clinic.
Hayes DJ; Moore JE
J Oncol Pharm Pract; 2021 Dec; 27(8):1861-1868. PubMed ID: 33148119
[TBL] [Abstract][Full Text] [Related]
17. Improved Adherence Rates and Clinical Outcomes of an Integrated, Closed-Loop, Pharmacist-Led Oral Chemotherapy Management Program.
Muluneh B; Schneider M; Faso A; Amerine L; Daniels R; Crisp B; Valgus J; Savage S
J Oncol Pract; 2018 Jun; 14(6):e324-e334. PubMed ID: 29799768
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of pharmacist interventions in a head and neck medical oncology clinic.
Lau KM; Saunders IM; Sacco AG; Barnachea LC
J Oncol Pharm Pract; 2020 Sep; 26(6):1390-1396. PubMed ID: 31937188
[TBL] [Abstract][Full Text] [Related]
19. Adherence to Oral Anticancer Medications After Implementation of an Ambulatory Adherence Program at a Large Urban Academic Hospital.
Curry MA; Chineke I; Redelico T; Terrell C; Bell W; Flood D; Mishra P; LaFollette J; Power S; Bernal-Mizrachi L
JCO Oncol Pract; 2020 Apr; 16(4):e350-e356. PubMed ID: 32048938
[TBL] [Abstract][Full Text] [Related]
20. Impact of pharmacist-led medication management in care transitions.
Yang S
BMC Health Serv Res; 2017 Nov; 17(1):722. PubMed ID: 29132369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
